Elisa H. Ignatius

520 total citations
14 papers, 327 citations indexed

About

Elisa H. Ignatius is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Elisa H. Ignatius has authored 14 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Elisa H. Ignatius's work include Tuberculosis Research and Epidemiology (11 papers), Mycobacterium research and diagnosis (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Elisa H. Ignatius is often cited by papers focused on Tuberculosis Research and Epidemiology (11 papers), Mycobacterium research and diagnosis (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Elisa H. Ignatius collaborates with scholars based in United States, South Africa and India. Elisa H. Ignatius's co-authors include Kelly E. Dooley, Elize Pietersen, Keertan Dheda, Frederick A. Sirgel, Robin M. Warren, Elizabeth M. Streicher, Paul D. van Helden, Anil Pooran, Maia Lesosky and Motasim Badri and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Elisa H. Ignatius

14 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa H. Ignatius United States 9 272 211 78 45 19 14 327
Lidya Chaidir Indonesia 12 303 1.1× 217 1.0× 231 3.0× 75 1.7× 4 0.2× 41 465
Afton Dorasamy South Africa 8 258 0.9× 251 1.2× 57 0.7× 51 1.1× 5 0.3× 9 332
Zhaojing Zong China 10 332 1.2× 278 1.3× 86 1.1× 127 2.8× 10 0.5× 17 398
Sangeeta Susan Thomas Singapore 5 145 0.5× 159 0.8× 30 0.4× 69 1.5× 9 0.5× 9 311
Lorenzo Guglielmetti France 14 483 1.8× 457 2.2× 187 2.4× 72 1.6× 8 0.4× 42 653
Fathima Rahman India 10 224 0.8× 187 0.9× 116 1.5× 25 0.6× 5 0.3× 19 290
J Bayona United States 9 306 1.1× 245 1.2× 125 1.6× 42 0.9× 5 0.3× 10 355
P T Davidson United States 9 239 0.9× 237 1.1× 86 1.1× 27 0.6× 6 0.3× 14 337
Sashen Moodley South Africa 5 196 0.7× 164 0.8× 45 0.6× 52 1.2× 7 0.4× 8 241
Hyungseok Kang South Korea 8 255 0.9× 187 0.9× 105 1.3× 41 0.9× 7 0.4× 14 304

Countries citing papers authored by Elisa H. Ignatius

Since Specialization
Citations

This map shows the geographic impact of Elisa H. Ignatius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa H. Ignatius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa H. Ignatius more than expected).

Fields of papers citing papers by Elisa H. Ignatius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa H. Ignatius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa H. Ignatius. The network helps show where Elisa H. Ignatius may publish in the future.

Co-authorship network of co-authors of Elisa H. Ignatius

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa H. Ignatius. A scholar is included among the top collaborators of Elisa H. Ignatius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa H. Ignatius. Elisa H. Ignatius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ignatius, Elisa H., Veronique de Jager, Caryn M. Upton, et al.. (2024). High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 210(3). 343–351. 6 indexed citations
2.
Ignatius, Elisa H., et al.. (2024). Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease. Tuberculosis. 146. 102482–102482. 5 indexed citations
4.
Lippincott, Christopher K., et al.. (2023). Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease. mSphere. 8(2). e0066522–e0066522. 14 indexed citations
5.
Chirehwa, Maxwell, Elisa H. Ignatius, Richard Court, et al.. (2022). Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis. Journal of Antimicrobial Chemotherapy. 77(9). 2489–2499. 7 indexed citations
6.
Dooley, Kelly E., Grace L. Barnes, Kim Narunsky, et al.. (2022). Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results. American Journal of Respiratory and Critical Care Medicine. 207(7). 929–935. 10 indexed citations
7.
Dedrick, Rebekah M., Krista G. Freeman, Asli Bahadirli-Talbott, et al.. (2022). Nebulized Bacteriophage in a Patient With Refractory Mycobacterium abscessus Lung Disease. Open Forum Infectious Diseases. 9(7). ofac194–ofac194. 20 indexed citations
8.
Ignatius, Elisa H., Kunbo Wang, Andrew H. Karaba, et al.. (2020). Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis. Open Forum Infectious Diseases. 8(1). ofaa598–ofaa598. 20 indexed citations
9.
Ignatius, Elisa H., Kelly E. Dooley, Rodney Dawson, et al.. (2020). A validated liquid chromatography tandem mass spectrometry assay for the analysis of pretomanid in plasma samples from pulmonary tuberculosis patients. Journal of Pharmaceutical and Biomedical Analysis. 195. 113885–113885. 9 indexed citations
10.
Ignatius, Elisa H., Kim Narunsky, Lubbe Wiesner, et al.. (2020). Pretomanid Pharmacokinetics in the Presence of Rifamycins: Interim Results from a Randomized Trial among Patients with Tuberculosis. Antimicrobial Agents and Chemotherapy. 65(2). 15 indexed citations
11.
Ignatius, Elisa H. & Susan Swindells. (2020). Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB. Current HIV/AIDS Reports. 17(6). 589–600. 6 indexed citations
12.
Hall, Casey D. Xavier, Justin C. Smith, Zara Khan, et al.. (2020). PrEParing for long-acting injectable PrEP in the South: perspectives from healthcare providers in Georgia. AIDS Care. 33(6). 706–711. 14 indexed citations
13.
Ignatius, Elisa H. & Kelly E. Dooley. (2019). New Drugs for the Treatment of Tuberculosis. Clinics in Chest Medicine. 40(4). 811–827. 36 indexed citations
14.
Pietersen, Elize, Elisa H. Ignatius, Elizabeth M. Streicher, et al.. (2014). Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study. The Lancet. 383(9924). 1230–1239. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026